The advisory panel laid out a detailed critique of the special dangers posed by menthols, concluding that "removal of menthol cigarettes from the marketplace would benefit public health in the United States." Still, it declined to take the most stringent step of recommending the discount cigarettes be removed from the markets, leaving that decision to the FDA, which has the final say on what, if any, action is taken.
